Go Pro

WORK Medical Technology Group (WOK) Competitors

WORK Medical Technology Group logo
$1.87 -0.02 (-1.06%)
As of 11:49 AM Eastern
This is a fair market value price provided by Massive. Learn more.

WOK vs. LUCYW, NXGLW, MDLN, ALC, and WST

Should you buy WORK Medical Technology Group stock or one of its competitors? WORK Medical Technology Group's main competitors and comparable companies include Innovative Eyewear (LUCYW), NEXGEL (NXGLW), Medline (MDLN), Alcon (ALC), and West Pharmaceutical Services (WST). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does WORK Medical Technology Group compare to Innovative Eyewear?

Innovative Eyewear (NASDAQ:LUCYW) and WORK Medical Technology Group (NASDAQ:WOK) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, earnings, valuation and risk.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innovative Eyewear
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
WORK Medical Technology Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Innovative Eyewear has higher earnings, but lower revenue than WORK Medical Technology Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Eyewear$3.41MN/AN/AN/AN/A
WORK Medical Technology Group$9.81MN/A-$1.07MN/AN/A

Company Net Margins Return on Equity Return on Assets
Innovative EyewearN/A N/A N/A
WORK Medical Technology Group N/A N/A N/A

In the previous week, Innovative Eyewear's average media sentiment score of 0.00 equaled WORK Medical Technology Group'saverage media sentiment score.

Company Overall Sentiment
Innovative Eyewear Neutral
WORK Medical Technology Group Neutral

Summary

WORK Medical Technology Group beats Innovative Eyewear on 2 of the 2 factors compared between the two stocks.

How does WORK Medical Technology Group compare to NEXGEL?

NEXGEL (NASDAQ:NXGLW) and WORK Medical Technology Group (NASDAQ:WOK) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, valuation, risk, media sentiment, dividends and analyst recommendations.

NEXGEL has higher revenue and earnings than WORK Medical Technology Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NEXGEL$12.07MN/AN/AN/AN/A
WORK Medical Technology Group$9.81MN/A-$1.07MN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NEXGEL
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
WORK Medical Technology Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, NEXGEL had 1 more articles in the media than WORK Medical Technology Group. MarketBeat recorded 1 mentions for NEXGEL and 0 mentions for WORK Medical Technology Group. NEXGEL's average media sentiment score of 0.00 equaled WORK Medical Technology Group'saverage media sentiment score.

Company Overall Sentiment
NEXGEL Neutral
WORK Medical Technology Group Neutral

Company Net Margins Return on Equity Return on Assets
NEXGELN/A N/A N/A
WORK Medical Technology Group N/A N/A N/A

Summary

NEXGEL beats WORK Medical Technology Group on 2 of the 3 factors compared between the two stocks.

How does WORK Medical Technology Group compare to Medline?

WORK Medical Technology Group (NASDAQ:WOK) and Medline (NASDAQ:MDLN) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, media sentiment, earnings, profitability and institutional ownership.

Company Net Margins Return on Equity Return on Assets
WORK Medical Technology GroupN/A N/A N/A
Medline N/A N/A N/A

Medline has higher revenue and earnings than WORK Medical Technology Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WORK Medical Technology Group$9.81MN/A-$1.07MN/AN/A
Medline$28.43B1.56$1.16B$0.7942.64

Medline has a consensus target price of $47.42, suggesting a potential upside of 40.77%. Given Medline's stronger consensus rating and higher possible upside, analysts clearly believe Medline is more favorable than WORK Medical Technology Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
WORK Medical Technology Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Medline
1 Sell rating(s)
5 Hold rating(s)
21 Buy rating(s)
2 Strong Buy rating(s)
2.83

In the previous week, Medline had 12 more articles in the media than WORK Medical Technology Group. MarketBeat recorded 12 mentions for Medline and 0 mentions for WORK Medical Technology Group. Medline's average media sentiment score of 0.35 beat WORK Medical Technology Group's score of 0.00 indicating that Medline is being referred to more favorably in the news media.

Company Overall Sentiment
WORK Medical Technology Group Neutral
Medline Neutral

Summary

Medline beats WORK Medical Technology Group on 8 of the 8 factors compared between the two stocks.

How does WORK Medical Technology Group compare to Alcon?

Alcon (NYSE:ALC) and WORK Medical Technology Group (NASDAQ:WOK) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation, media sentiment and earnings.

Alcon presently has a consensus price target of $84.96, suggesting a potential upside of 30.06%. Given Alcon's stronger consensus rating and higher probable upside, analysts plainly believe Alcon is more favorable than WORK Medical Technology Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alcon
1 Sell rating(s)
6 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.63
WORK Medical Technology Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Alcon has a net margin of 5.92% compared to WORK Medical Technology Group's net margin of 0.00%. Alcon's return on equity of 7.29% beat WORK Medical Technology Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Alcon5.92% 7.29% 5.09%
WORK Medical Technology Group N/A N/A N/A

Alcon has higher revenue and earnings than WORK Medical Technology Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alcon$10.40B3.11$980M$1.3149.87
WORK Medical Technology Group$9.81MN/A-$1.07MN/AN/A

Alcon has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market. Comparatively, WORK Medical Technology Group has a beta of 1.75, meaning that its share price is 75% more volatile than the broader market.

53.9% of Alcon shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Alcon's average media sentiment score of 0.33 beat WORK Medical Technology Group's score of 0.00 indicating that Alcon is being referred to more favorably in the media.

Company Overall Sentiment
Alcon Neutral
WORK Medical Technology Group Neutral

Summary

Alcon beats WORK Medical Technology Group on 11 of the 12 factors compared between the two stocks.

How does WORK Medical Technology Group compare to West Pharmaceutical Services?

WORK Medical Technology Group (NASDAQ:WOK) and West Pharmaceutical Services (NYSE:WST) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, risk and institutional ownership.

West Pharmaceutical Services has higher revenue and earnings than WORK Medical Technology Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WORK Medical Technology Group$9.81MN/A-$1.07MN/AN/A
West Pharmaceutical Services$3.07B8.59$493.70M$7.8148.05

In the previous week, West Pharmaceutical Services had 16 more articles in the media than WORK Medical Technology Group. MarketBeat recorded 16 mentions for West Pharmaceutical Services and 0 mentions for WORK Medical Technology Group. West Pharmaceutical Services' average media sentiment score of 0.61 beat WORK Medical Technology Group's score of 0.00 indicating that West Pharmaceutical Services is being referred to more favorably in the news media.

Company Overall Sentiment
WORK Medical Technology Group Neutral
West Pharmaceutical Services Positive

West Pharmaceutical Services has a consensus price target of $382.00, suggesting a potential upside of 1.79%. Given West Pharmaceutical Services' stronger consensus rating and higher possible upside, analysts plainly believe West Pharmaceutical Services is more favorable than WORK Medical Technology Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
WORK Medical Technology Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
West Pharmaceutical Services
0 Sell rating(s)
2 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.86

West Pharmaceutical Services has a net margin of 16.98% compared to WORK Medical Technology Group's net margin of 0.00%. West Pharmaceutical Services' return on equity of 20.11% beat WORK Medical Technology Group's return on equity.

Company Net Margins Return on Equity Return on Assets
WORK Medical Technology GroupN/A N/A N/A
West Pharmaceutical Services 16.98%20.11%14.83%

WORK Medical Technology Group has a beta of 1.75, suggesting that its stock price is 75% more volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.14, suggesting that its stock price is 14% more volatile than the broader market.

93.9% of West Pharmaceutical Services shares are owned by institutional investors. 0.6% of West Pharmaceutical Services shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

West Pharmaceutical Services beats WORK Medical Technology Group on 12 of the 13 factors compared between the two stocks.

Get WORK Medical Technology Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for WOK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WOK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WOK vs. The Competition

MetricWORK Medical Technology GroupHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$5.56B$7.29B$13.30B
Dividend YieldN/A1.80%2.53%12.80%
P/E RatioN/A25.39275.5325.70
Price / SalesN/A72.48688.53115.85
Price / CashN/A33.1128.0434.72
Price / BookN/A5.9310.616.40
Net Income-$1.07M$151.55M$3.49B$358.29M
7 Day Performance2.75%1.48%1.56%1.88%
1 Month Performance-17.98%-3.42%-2.08%-2.74%
1 Year Performance-100.00%6.57%17.56%6.04%

WORK Medical Technology Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WOK
WORK Medical Technology Group
N/A$1.87
-1.1%
N/A-100.0%$0.00$9.81MN/A226
LUCYW
Innovative Eyewear
N/A$0.03
-15.3%
N/AN/A$0.00$3.41MN/A9
NXGLW
NEXGEL
N/A$0.01
+5.9%
N/AN/A$0.00$12.07MN/A10
MDLN
Medline
3.0033 of 5 stars
$32.99
+2.7%
$47.42
+43.7%
N/A$42.22B$28.43BN/A45,000
ALC
Alcon
3.3668 of 5 stars
$66.31
-2.1%
$84.96
+28.1%
-16.0%$33.52B$10.40B50.6225,942

Related Companies and Tools


This page (NASDAQ:WOK) was last updated on 9/22/2026 by MarketBeat.com Staff.
From Our Partners